Abstract:Background: Technology experts foresee that nanotechnology is the next industrial revolution and it has great potential to bring solutions to many challenges of global relevance in terms of a diverse range of applications. Efficiency-driven economies are transforming into innovation-driven economies where Intellectual Property (IP) plays a pivotal role in achieving a competitive advantage. Whereas industry analysts assert that IP roadblocks will be a severe detriment to the development of nanotechnology due to infringements and high-profile patent battles. Various authors have made a significant effort to analyse the implications of IP on nanotechnology but most of the published literature covers only the years 2000- 2010. Data and insights pertaining to recent developments are lagging behind. Therefore, the objective of this review was to explore cutting-edge empirical evidence towards emerging trends of Intellectual Property protection in nanotechnology, thereby to provide insights aimed at unleashing the full potential of nanotechnology innovation for socio-economic advantage. Materials and methods: Patent information over the period 2000 to 2018 was collated and analysed to determine the latest trends. To gain a global perspective, nanotechnology patents issued by the United States Patent and Trademark Office (USPTO) and nanotechnology patents published in the 'PatentScope' of the World Intellectual Property Organization (WIPO) were surveyed along with literature in relation to nanotechnology commercialization and litigation. Results: Our study revealed that worldwide protection of Intellectual Property in nanotechnology has steadily been increasing year-on-year accounting 3.3 million patent applications filed in 2018 in which China and U.S. are dominating. The other main contributors are Japan, Germany Republic of Korea, France and U.K. Asia has emerged as the single region to file more than half of total filings for the first time thus shifting global IP landscape from Europe to Asia. Another notable finding is that there is a significant growth in trademark registration in many of the leading economies. Top five technology fields with high international patenting activity are computer technology, medical technology, digital communication, electrical machinery and pharmaceuticals where computer technology is dominating. More than 90% of the total patents are granted on materials, devices and processes developed as basic building blocks of nanotechnology at laboratory level which sound as more downstream innovations in the short-term. Amid the upward trends in nanotechnology patenting, newly emerging obstacles pose risks to innovation. A key finding of the present study is that the increasing trend of patent litigation almost follows the same path of patent grants indicating a positive correlation. A global prominence of middle-income and low-income countries in patent filing is yet to emerge which foreshadows an IP divide. Discussions: A secondary market for patent assets is pronounced with many new types of players leading to a high cost of patenting nanotechnology. These trends foreshadow a surge of patent filings in the years to come and.the patent offices will be confronted with that 'surge' of patent applications of increased complexity and multidisciplinary nature..Patent offices with inadequate efficacy will ultimately produce lowquality patents along with a difficulty to enter into markets and will facilitate exploiting of the IP legal systems to extract rewards for infringement without contributing to innovation or social prosperity of nations. Conclusion: Insights and recommendations given in this paper will enable nanotechnology researchers, inventors, technopreneurs and investors to understand recent trends and global perspectives on implications of IP in nanotechnology and intensifying IP battle thereby to contemplate and succeed in their roadmaps towards leveraging on nanotechnology.

Ethic and patents: immiscible realities?

Ethico-legal issues in biomedicine patenting: A patent professional viewpoint

To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health

Open Access, Intellectual Property, and How Biotechnology Becomes a New Software Science

Patents in the era of genomics: an overview

Ethics and patentability in biotechnology

Genome research: fulfilling the public's expectations for knowledge and commercialization

The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology

Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies

Intellectual Property in 3D Printing and Nanotechnology

International conflicts over patenting human DNA sequences in the United States and the European Union: an argument for compulsory licensing and a fair-use exemption

Enabling responsible public genomics

Prior Consents: Preventing Offensive Genetic Engineering Patents Against Indigenous People's Rights

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research

Nanotechnology and Protection of Intellectual Property: Emerging Trends

The quest for market exclusivity in biotechnology: navigating the patent minefield

Access to stem cells and data: persons, property rights, and scientific progress

Biobank donation in search of public benefits and the potential impact of intellectual property rights over access to health-technologies developed: A focus on the bioethical implications

Intellectual property rights and innovation: Evidence from the human genome

Property rights in genetic information

Whose body is it anyway? Human cells and the strange effects of property and intellectual property law